002082.SZ Stock - Wanbangde Pharmaceutical Holding Group Co., Ltd.
Unlock GoAI Insights for 002082.SZ
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $1.44B | $1.54B | $1.79B | $1.93B | $13.70B |
| Gross Profit | $596.19M | $623.76M | $933.85M | $931.33M | $1.34B |
| Gross Margin | 41.3% | 40.5% | 52.3% | 48.2% | 9.8% |
| Operating Income | $60.14M | $27.00M | $128.66M | $375.15M | $346.60M |
| Net Income | $55.44M | $49.21M | $93.26M | $166.51M | $284.94M |
| Net Margin | 3.8% | 3.2% | 5.2% | 8.6% | 2.1% |
| EPS | $0.09 | $0.08 | $0.15 | $0.27 | $0.47 |
Wanbangde Pharmaceutical Holding Group Co., Ltd. engages in the research, development, production, and sale of Chinese medicines, APIs, and preparations. It also develops medical devices, including orthopaedic implant devices, medical equipment, and protective equipment, as well as disposable bacteria medical polymer consumables; and provides hospital engineering services. The company was formerly known as Wanbangde New Building Materials Co., Ltd. and changed its name to Wanbangde Pharmaceutical Holding Group Co., Ltd. in April 2020. Wanbangde Pharmaceutical Holding Group Co., Ltd. was founded in 1985 and is based in Taizhou, China.
Visit WebsiteEarnings History & Surprises
002082.SZEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2025 | Sep 30, 2025 | — | $-0.01 | — | — |
Q2 2025 | Jun 30, 2025 | — | $-0.00 | — | — |
Q2 2025 | Apr 28, 2025 | — | $0.02 | — | — |
Q1 2025 | Mar 31, 2025 | — | $0.02 | — | — |
Q4 2024 | Oct 29, 2024 | — | $0.01 | — | — |
Q3 2024 | Aug 29, 2024 | — | $0.01 | — | — |
Q2 2024 | Apr 29, 2024 | — | $0.05 | — | — |
Q2 2024 | Apr 26, 2024 | — | $0.09 | — | — |
Q4 2023 | Oct 27, 2023 | — | $-0.06 | — | — |
Q3 2023 | Aug 28, 2023 | — | $0.01 | — | — |
Q2 2023 | Apr 26, 2023 | — | $-0.09 | — | — |
Q1 2023 | Mar 31, 2023 | — | $0.04 | — | — |
Q3 2022 | Sep 30, 2022 | — | $0.15 | — | — |
Q2 2022 | Jun 30, 2022 | — | $0.05 | — | — |
Q2 2022 | Apr 29, 2022 | — | $0.04 | — | — |
Q2 2022 | Apr 14, 2022 | — | $0.02 | — | — |
Q4 2021 | Oct 27, 2021 | — | $0.06 | — | — |
Q3 2021 | Aug 27, 2021 | — | $0.12 | — | — |
Q2 2021 | Apr 28, 2021 | — | $0.24 | — | — |
Q1 2021 | Mar 31, 2021 | — | $0.04 | — | — |
Latest News
Frequently Asked Questions about 002082.SZ
What is 002082.SZ's current stock price?
What is the analyst price target for 002082.SZ?
What sector is Wanbangde Pharmaceutical Holding Group Co., Ltd. in?
What is 002082.SZ's market cap?
Does 002082.SZ pay dividends?
Similar Stocks
Basic Materials SectorExplore stocks similar to 002082.SZ for comparison